These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30128013)

  • 1. Role of YAP in lung cancer resistance to cisplatin.
    Song J; Xie LX; Zhang XY; Hu P; Long MF; Xiong F; Huang J; Ye XQ
    Oncol Lett; 2018 Sep; 16(3):3949-3954. PubMed ID: 30128013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of GST-
    Wang W; Wei J; Tu X; Ye X
    Biomed Res Int; 2021; 2021():9142364. PubMed ID: 34840986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells.
    Wang X; Wu B; Zhong Z
    Oncol Lett; 2018 Jul; 16(1):585-593. PubMed ID: 29928445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
    Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells.
    Lu T; Sun L; Zhu X
    Biomed Pharmacother; 2018 Sep; 105():1269-1275. PubMed ID: 30021363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
    J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6.
    Yang L; Lin Z; Wang Y; Gao S; Li Q; Li C; Xu W; Chen J; Liu T; Song Z; Liu G
    Mol Carcinog; 2018 Mar; 57(3):419-428. PubMed ID: 29144562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neoplastic effect of mangiferin on human ovarian adenocarcinoma OVCAR8 cells via the regulation of YAP.
    He W; You Y; Du S; Lei T; Wang H; Li X; He X; Tong R; Wang Y
    Oncol Lett; 2019 Jan; 17(1):1008-1018. PubMed ID: 30655860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.
    Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation.
    Zhang Y; Liu X; Dang W; Liu L
    Carcinogenesis; 2023 Aug; 44(5):426-435. PubMed ID: 37105709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK/mitochondrial pathway.
    Liu Y; Chen X; Gu Y; Zhu L; Qian Y; Pei D; Zhang W; Shu Y
    Neoplasma; 2015; 62(1):61-71. PubMed ID: 25563368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.
    Qin X; Qiu F; Zou Z
    Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
    Su J; Wu S; Tang W; Qian H; Zhou H; Guo T
    Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin.
    Hu W; Jin P; Liu W
    Cell Physiol Biochem; 2016; 38(3):1199-208. PubMed ID: 26982182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
    Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
    Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into the Clinical Implications of Yes-Associated Protein in Lung Cancer: Roles in Drug Resistance, Tumor Immunity, Autophagy, and Organoid Development.
    Yoo G; Park D; Kim Y; Chung C
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34202980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages.
    Xu Y; Xu Z; Li Q; Guo L; Wang Y; Zhou J; Wang G; Liu Y
    J Immunol Res; 2019; 2019():7478538. PubMed ID: 31781681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.